Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CLOV | CENT |
|---|---|---|
| Price | $4.68 | $39.70 |
| Change today | ▲ 6.85% | ▼ 0.28% |
| Market cap | $2.49B | $2.48B |
| Return, 3 months | -6.4% | -7.2% |
| Return, year to date | +99.1% | +23.5% |
| Return, 1 year | +78.6% | +27.3% |
| P/E (TTM) | -93.6 | 14.7 |
| P/B | 6.6 | 1.4 |
| P/E percentile vs own 5y | 0th | – |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +55.6% | -8.2% |
| Net profit growth (YoY) | +364.7% | -5.7% |
| Gross margin | 20.6% | 35.9% |
| Operating margin | 3.8% | 14.3% |
| Net margin | 3.8% | 10.2% |
| Return on equity | – | – |
| Analyst target vs. price | +17.5% | +24.7% |
| Analyst buy share | 67% | 50% |
| RSI (14) | 58 | 40 |
| 30-day volatility | 51.8% | 17.0% |
| Max drawdown, 1 year | -55.5% | -16.4% |
| Trend read | Strong uptrend | Leaning bearish |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
